We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNT
2801
Fluent
FLNT
$104M
| $156K | ﹤0.01% |
7,235
+2,209
| +44% | +$40.3K |
|
2802
Harvard Bioscience
HBIO
$28.7M
| $156K | ﹤0.01% |
4,891
+1,584
| +48% | +$62.4K |
|
2803
eGain
EGAN
$198M
| $155K | ﹤0.01% |
23,667
+7,688
| +48% | +$55.9K |
|
2804
Ponce Financial Group
PDLB
$495M
| $155K | ﹤0.01% |
+16,959
| New | +$162K |
|
2805
UBS Group
UBS
$176B
| $154K | ﹤0.01% |
12,450
| – | – |
|
|
SFS
2806
DELISTED
Smart & Final Stores, Inc.
SFS
| $154K | ﹤0.01% |
32,495
+10,007
| +44% | +$55.2K |
|
2807
OP Bancorp
OPBK
$235M
| $153K | ﹤0.01% |
17,246
+5,522
| +47% | +$54.8K |
|
|
USAK
2808
DELISTED
USA Truck Inc
USAK
| $153K | ﹤0.01% |
+10,224
| New | +$188K |
|
|
JAX
2809
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $153K | ﹤0.01% |
18,550
+5,523
| +42% | +$54.4K |
|
2810
Clearfield
CLFD
$459M
| $152K | ﹤0.01% |
15,332
+4,902
| +47% | +$58.2K |
|
|
SYBX
2811
DELISTED
Synlogic
SYBX
| $152K | ﹤0.01% |
1,450
+454
| +46% | +$59.8K |
|
|
ICD
2812
DELISTED
Independence Contract Drilling, Inc.
ICD
| $152K | ﹤0.01% |
2,435
+868
| +55% | +$65.3K |
|
|
GDP
2813
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $152K | ﹤0.01% |
+11,226
| New | +$158K |
|
2814
Arlo Technologies
ARLO
$1.73B
| $148K | ﹤0.01% |
+14,791
| New | +$177K |
|
|
BRY
2815
DELISTED
Berry Corp
BRY
| $147K | ﹤0.01% |
16,761
+6,013
| +56% | +$80.8K |
|
|
OPTN
2816
DELISTED
OptiNose
OPTN
| $147K | ﹤0.01% |
1,581
+584
| +59% | +$83.4K |
|
|
AMR
2817
DELISTED
Alta Mesa Resources Inc
AMR
| $147K | ﹤0.01% |
147,380
+43,557
| +42% | +$110K |
|
|
YELL
2818
DELISTED
Yellow Corporation Common Stock
YELL
| $147K | ﹤0.01% |
46,568
+13,877
| +42% | +$88.3K |
|
2819
Rockwell Medical
RMTI
$28.7M
| $146K | ﹤0.01% |
586
+188
| +47% | +$74.8K |
|
|
LEAF
2820
DELISTED
Leaf Group Ltd.
LEAF
| $146K | ﹤0.01% |
21,351
+7,188
| +51% | +$61.7K |
|
2821
Silvercrest Asset Management
SAMG
$79.2M
| $144K | ﹤0.01% |
+10,850
| New | +$151K |
|
2822
Banco Santander
SAN
$209B
| $144K | ﹤0.01% |
33,519
+269
| +0.8% | +$1.22K |
|
2823
INNOVATE Corp
VATE
$106M
| $142K | ﹤0.01% |
5,362
+1,755
| +49% | +$74K |
|
2824
Vuzix
VUZI
$213M
| $142K | ﹤0.01% |
29,595
+10,029
| +51% | +$58.5K |
|
2825
Mitsubishi UFJ Financial
MUFG
$253B
| $141K | ﹤0.01% |
28,929
+178
| +0.6% | +$1.01K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.